Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy
Författare
Summary, in English
Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (
Publiceringsår
2016-04-01
Språk
Engelska
Sidor
205-210
Publikation/Tidskrift/Serie
Clinical Kidney Journal
Volym
9
Issue
2
Dokumenttyp
Artikel i tidskrift
Förlag
Oxford University Press
Ämne
- Urology and Nephrology
Nyckelord
- critically ill patients
- CRRT
- hypophosphataemia
- intensive care medicine
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 2048-8505